Chlorthalidone

氯噻酮

Report date: 2026/04/03 20:03:44
NME

Base Information

Drug NameChlorthalidone
Drug Alias Name氯肽酮Chlortalidone氯塞酮C52R2Thalitone +[11] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionThiazide-sensitive sodium-chloride cotransporter inhibitors
TargetsThiazide-sensitive sodium-chloride cotransporter
Therapy Area/IndicationsHypercalciuriaEdemaDiabetes Mellitus, Type 1 +[7] 
Global Approved IndicationsEdemaHypertensionKidney Calculi +[4] 
Approved Indications in ChinaEdemaHypertensionKidney Calculi +[4] 
Original Approved Country/TerritorySwitzerland
Original Approved Date1959/01/01
Country/TerritoryUnited StatesSwitzerlandMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesSanofi
China Registration ClassN/A

Develop Information

Active CompaniesCasper Pharma LlcSanofiPRM Pharma LLC +[4] 
Inactive CompaniesUniversity Of RochesterIndiana UniversitySanofi-Aventis U.S. Llc
Active IndicationsEdemaHypertensionKidney Calculi +[4] 
Inactive IndicationsHypercalciuriaDiabetes Mellitus, Type 1Renal Insufficiency, Chronic

Other Information

ATC CodeC03BA04
Related LinksWikipediaDrugBankKEGG